Lupin settles US patent dispute with Astellas Pharma for $90 million (Soban News)

The settlement resolves Lupin’s ‌pending litigation with Astellas and ​enables the company to continue marketing Mirabegron in the United States​The settlement resolves Lupin’s ‌pending litigation with Astellas and ​enables the company to continue marketing Mirabegron in the United States ​Latest News [ SOBAN NEWS: International and National ]